# Beaconcure

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beaconcure

- Industry: Biotechnology
- Headquarters: Tel Aviv, Israel
- Website: www.beaconcure.com
- Total disclosed funding: $9.9M
- Latest round: Series B (Feb 27, 2023)
- Investors on record: 1

## About

Based in Tel Aviv, Israel, and founded in 2016, Beaconcure operates as a business support service provider which offers artificial intelligence technology-based services to biopharmaceutical companies for drug development and regulatory approvals. The company was Co-founded by Yoran Bar (CEO) and Ilan Carmeli (COO). In February 2023, Beaconcure raised USD 9.89 million in series B funding led by NewVale Capital. As of 2022, the firm is having 2 offices in Israel and US.

The company offers Biopharmaceutical companies and CROs automated clinical trial data processing solutions. It offers a cloud-based, Artificial Intelligence-driven clinical data analytics platform, designed with Pfizer to accelerate the introduction of new drugs and vaccines to the market for the benefit of patients worldwide. The platform helps clients to convert static data into a machine-readable format and automate manual checks. It helps in tracking and reporting study progress and audit trial.

The company plans to use the February 2023 funding to build its position, expand its commercial organization and broaden its platform.

## Funding rounds

- Series B, Feb 27, 2023, $9.9M — NewVale Capital

## Investors

- NewVale Capital (https://capitalatlas.ai/funds/newvale-capital) — Series B